An inhaled tumor necrosis factor-alpha-derived TIP peptide improves the pulmonary function in experimental lung injury

Acta Anaesthesiol Scand. 2013 Mar;57(3):334-41. doi: 10.1111/aas.12034. Epub 2012 Dec 6.

Abstract

Introduction: The lectin-like domain of TNF-α enhances the fluid clearance across the alveolar barrier. For experimental purposes, the lectin-like domain can be mimicked by a synthetic peptide representing the TIP-motif of TNF-α. The present study aims to assess the acute effect of TIP on the pulmonary function in a porcine model of acute respiratory distress syndrome (ARDS).

Methods: Lung injury was induced in 16 pigs (25-27 kg) by bronchoalveolar lavage followed by injurious ventilation. Following randomisation, either nebulised TIP (1 mg/kg; AP301, APEPTICO, Vienna, Austria) or water for injection (control group) was administered. During 5 h of monitoring, the extravascular lung water index (EVLWI), the quotient of partial pressure of oxygen and inspired oxygen concentration (PaO(2) /FiO(2) ) and the pulmonary shunt fraction were repetitively assessed. The data were evaluated by an analysis of variance including Bonferroni-Holm correction.

Results: Comparable baseline conditions in both groups were achieved. Ventilatory parameters were standardised in both groups. In the TIP group, a significant reduction of the EVLWI and a simultaneous increase in the PaO(2) /FiO(2) ratio was shown (each P < 0.0001). No changes in the control group were observed (EVLWI: P = 0.43, PaO(2) /FiO(2) : P = 0.60). The intergroup comparison demonstrates a significant advantage of TIP inhalation over placebo (EVLWI: P < 0.0001, PaO(2) /FiO(2) : P = 0.004, shunt fraction: P = 0.0005).

Conclusions: The inhalation of TIP induces an amelioration of clinical surrogate parameters of the lung function in a porcine lung injury model. By mimicking the lectin-like domain, the synthetic TIP peptide AP301 is an innovative approach as supportive therapy in ARDS.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Bronchoalveolar Lavage
  • Extravascular Lung Water / physiology
  • Hemodynamics / physiology
  • Lung / drug effects*
  • Lung Injury / drug therapy*
  • Lung Injury / physiopathology
  • Oxygen / blood
  • Partial Pressure
  • Peptide Fragments / chemistry
  • Peptide Fragments / therapeutic use*
  • Respiration, Artificial
  • Respiratory Distress Syndrome / drug therapy
  • Respiratory Distress Syndrome / physiopathology
  • Respiratory Function Tests
  • Swine
  • Tumor Necrosis Factor-alpha / chemistry
  • Tumor Necrosis Factor-alpha / therapeutic use*

Substances

  • Peptide Fragments
  • Tumor Necrosis Factor-alpha
  • Oxygen